Beyond the Abstract - Pathological Evidence of Necrosis in Recurrent Renal Mass Following Treatment with Sunitinib
BERKELEY, CA (UroToday.com) - Sunitinib is a highly potent, selective inhibitor of certain protein tyrosine kinases, including VEGF-R types 1 to 3, PDGF-R- , and PDGF-R-ß.
|
UroToday, 1802 Fifth Street, Berkeley CA 94710 510.540.0930 (fax), info@urotoday.com ISSN 1939-4810
Privacy Policy | © 2009 UroToday ® All Rights Reserved |
